Robert Bindert Huizinga - Sep 7, 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: EVP of Research
Signature: /s/ Robert Bindert Huizinga
Stock symbol: AUPH
Transactions as of: Sep 7, 2021
Transactions value $: -$91,500
Form type: 4
Date filed: 9/8/2021, 04:03 PM
Previous filing: May 11, 2021
Next filing: Sep 14, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Sale	-$91.5K	-5K	-3.48%	$18.30	139K	Sep 7, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021.
F2	The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $18.30 to $18.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2021.

The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $18.30 to $18.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.